Summary
The binding of prostaglandin (PG) E1 and Iloprost, a chemically stable PGI2-analogue, to purified plasma cell membranes (LPZM) from liver tissue samples obtained at surgery revealed heterogeneity of the binding sites identifying high and low affinity subpopulations. In contrast to these findings only high affinity binding sites were characterized for PGE2. Displacement studies exhibited the highest competition for the PGE1-sites by PGE1 and subsequently by PGE2, Iloprost, PGD2 and PGF2 α. The binding of PGE2 to the hepatic receptor could be best displaced by PGE2 and subsequently by PGE1 and Iloprost, PGD2 and PGF2 α. In addition, PGE1, PGE2 and Iloprost enhanced cAMP-production dose-dependently over baseline. Clinical studies revealed a remarkably lower binding capacity for PGE1 in hepatocellular cancer tissue than in noral liver parenchyma. The different binding behaviour of PGE1 (Iloprost) and PGE2 for the first time provides evidence that PGE1 and PGI2 like at platelet membranes occupate the same receptor also at human LPZM. Since a reasonable number of binding sites for these substances and an enhanced cAMP-production were shown in the liver, the study indicates a regulatory role of PGs in hepatic function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Bmax:
-
gesättigte Rezeptorzahl
- cAMP:
-
zyklisches 3′5′-Adenosin-Monophosphat
- GS:
-
Gesamtbindung
- Kd:
-
Äquilibriumsdissoziationskonstante
- LPZM:
-
Leberplasmazellmembranen
- PG:
-
Prostaglandin
- SB:
-
Spezifische Bindung
- US:
-
Unspezifische Bindung
Literatur
Blair IA, McDermot J (1981) The binding of [3H]-prostacyclin to membranes of a neuronal somatic hybrid. Brit J Pharmacol 72:435–441
Bradford MM (1976) A rapid and sensitive method for the quantification of microgramm quantities of protein utilizing the principle of protein dye binding. Analyt Biochem 72:248–254
Clarke WR, Jones LR, Lefkowitz LJ (1979) Hepatic α-adrenergic receptors: identification and subcellular localization using 3H-dihydroergocriptine. J Biol Chem 253:5975–5979
Dutta-Roy AK, Sinha AK (1987) Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. J Biol Chem 262:12685–12690
Fernandez-Botran R, Tsuneao S (1984) Prostaglandin-sensitive adenylate cyclase of a murine macrophage-like cell line (P388D1): isolation and partial characterization of PGE2-binding proteins. J Immunology 133:2662–2669
Garrity MJ, Andreasen TJ, Storm DR, Robertson RP (1983) Prostaglandin E-induced heterologous desensitization of hepatic adenylate cyclase. J Biol Chem 258:8692–8697
Garrity MJ, Westcott KR, Eggerman TL, Andersen NH, Storm DR, Robertson RP (1983) Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase. Am J Physiol 244:367–372
Garrity MJ, Brass EP, Robertson RP (1987) PGE binding in isolated hepatocytes: regulation during fasting. Adv Prostagl Thromb Leucotr Res 17:686–690
Hall JM, Strange PG (1984) The use of a prostacyclin analogue, 3H-iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells. Bioscience Rep 4:941–949
Lavis VR, Strada SJ, Rose CP, Herschl EM, Thompson WJ (1980) Comparison of the responses of freshly isolated and cultured human monocyts and P388D1 cells to agents affecting cyclic AMP metabolism. J Lab Clin Med 96:551–558
Lombroso M, Nicosia S, Paoletti R, Whittle BJR, Moncada S, Vane JR (1984) The use of stable prostaglandins to investigate prostacyclin (PGI2)-sensitive adenylate cyclase in human platelets. Prostaglandins 27:321–330
Neville DM (1968). Isolation of an organic specific protein antigen from cell-surface membranes of rat liver. Biochim. Biophys. Acta 154:540–552
Ruwart MJ, Rush BD, Friedle NM, Piper RC, Kolaja GJ (1981). Protective effect of 16,16-dimethyl PGE2 on the liver and kidney. Prostaglandins 21:97–102
Sikujara O, Monden M, Toyoshima K, Okamura J, Koak G (1983). Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury. Tranplantation, 36:238–243
Sinzinger H, Virgolini I (1988). Prostacyclin-formation. ISI Atlas of Science. Pharmacology 105–108
Sutherland EW, Rall TW (1957). The properties of an adenine ribonucleotide produced with cellular particals, ATP, Mg++ and epinephrine or glucagon. J Am Chem Soc, 79:3608–3613
Virgolini I, Hermann M, Sinzinger H (1988) Decrease of prostaglandin I2 high-affinity binding sites in thyroid cancer. Brit J Cancer 58:584–588
Virgolini I, Fanzoy U, Hermann M, Müller C, Sinzinger H (1987). Prostaglandinrezeptoren in der Leber. Acta Med Austriaca 14:28
Virgolini I, Weiss K, Hermann M, Sinzinger H, Höfer R (1989). Verlust von hochaffinen Bindungsstellen für Prostacyclin (PGI2) bei Patienten mit Morbus Basedow. Nuklearmedizin (in Druck)
Virgolini, I (1987). Characterization of PGI2-receptor binding sites on normal and pathologically altered human thyroid tissue. In: Sinzinger H, Schrör K, Peskar P (Eds) Eicosanoids and Fatty Acids, Vol 3, pp 1–90
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Virgolini, I., Weiss, K., Hermann, M. et al. Prostaglandin-Interaktion in der menschlichen Leber. Klin Wochenschr 67, 1229–1235 (1989). https://doi.org/10.1007/BF01745294
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01745294